Tuesday, February 27, 2024

Polaris of Enlightenment

Tuesday, February 27, 2024

Polaris of Enlightenment

Texas sues Pfizer over allegations of ineffective pediatric drugs

Published 26 November 2023
- By Editorial Staff
The scandal-ridden pharmaceutical giant is back in the spotlight.

Pfizer is accused of having supplied ADHD medication for children despite knowing that it may be ineffective. The drug was distributed primarily to low-income families through a state health insurance program.

Texas attorney general Ken Paxton filed a lawsuit in Harrison County District Court against Pfizer and its supplier Tris Pharma. They are accused of manipulating quality control tests of the drug Quillivant XR, allegedly manipulating test results between 2012 and 2018 to meet federal legal requirements.

It was revealed that properly conducted tests showed that the drug often failed to dissolve as intended, preventing its effective release in the body. Despite this knowledge, Pfizer allegedly persuaded officials to include Quillivant XR in the Texas Medicaid program, which serves low-income families and people with disabilities.

Paxton points out that several families who received the drug have reported its ineffectiveness. The companies are now accused of defrauding the health insurance program.

“Defrauding our state”

– The lengths to which this company and their leadership went to defraud our state and the patients taking this medication are shocking, Paxton said in a press release and continues:

– Pharmaceutical companies who violate the public’s trust and hurt the people of Texas will be brought to justice to the fullest extent of the law.

Pfizer said in a response that it has reviewed the allegations several times and found nothing that would compromise the safety of the product. The company also said it believes the case will be dismissed. Tris Pharma also denies the allegations.

According to Pfizer’s 2022 annual report, the company received a lawsuit from federal prosecutors in New York during 2018 regarding its relationship with Tris Pharma and the production of Quillivant, but has received no further information since.


More from the front page




Share via
Tuesday, February 27, 2024
Search
Search

NEWS

OTHER

SOCIAL MEDIA

Subscribe to our newsletter!

© 2022-2024 The Nordic Times TNT.
All rights reserved.

Our independent journalism needs your support!
We appreciate all of your donations to keep us alive and running.

Our independent journalism needs your support!
Consider a donation.

You can donate any amount of your choosing, one-time payment or even monthly.
We appreciate all of your donations to keep us alive and running.

Dont miss another article!

Sign up for our newsletter today!

Take part of uncensored news – free from industry interests and political correctness from the Polaris of Enlightenment – every week.

Send this to a friend
Share via
Send this to a friend